Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use

Post time Yesterday 23:15

journal：Expert Opinion on Biological Therapy

Authors：Matteo Megna; Giuseppe Lauletta; Michela D’Agostino; Nello Tommasino; Antonia Salsano; Matteo Noto; Claudio Brescia; Luciano Foggia; Lorenzo Scaramuzzino; Luca Potestio

Published date：2025-7-3

DOI：10.1080/14712598.2025.2519525

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/14712598.2025.2519525

Article link：https://doi.org/10.1080/14712598.2025.2519525

Article Source：Informa UK Limited。

Remark：

Post time 11 hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Taylor&Francis] Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use